Chaim Hurvitz, Director at NRX Pharmaceuticals, holds 2.21M shares in NRX Pharmaceuticals (Ticker: NRXP), holds ― shares in Dror Ortho-Design (Ticker: DROR). Most recently, Chaim Hurvitz Bought ― shares of NRX Pharmaceuticals on Sep 11, 2023 for an estimated value of 19.60K.
What is the percentage of profitable transactions made by Chaim Hurvitz?
The percentage of profitable transactions made by Chaim Hurvitz is 0%.
What is the average return per transaction made by Chaim Hurvitz?
The average return per transaction made by Chaim Hurvitz is -52.30%.
What stocks does Chaim Hurvitz hold?
Chaim Hurvitz holds: NRXP, DROR stocks.
What was Chaim Hurvitz’s latest transaction?
Chaim Hurvitz latest transaction was an Informative Buy of $19.60K.
What was Chaim Hurvitz's most profitable transaction?
Chaim Hurvitz’s most profitable transaction was an Informative Buy of NRXP stock on September 11, 2023. The return on the trade was -33.90%.
What is Chaim Hurvitz's role in NRX Pharmaceuticals?
Chaim Hurvitz's role in NRX Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.